News Search Results
Feb 12, 2025, 08:30 ET Emmes Group advances data security as ISMS certified ISO compliant
companies throughout the world. The company has built industry leading capabilities in cell and gene therapy, vaccines and infectious diseases, ophthalmology, and neuroscience. Today, we are part of the Emmes Group, helping transform the future of clinical research. Learn more at
More news about: Emmes Group
Feb 12, 2025, 08:21 ET Four AMSURG Centers Recognized With Prestigious Press Ganey 2024 Human Experience Awards
health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. With a focus on strategic growth and innovation, AMSURG is committed to transforming the future of ambulatory surgery center care
More news about: AMSURG Corporation
Feb 12, 2025, 06:00 ET Clínica de Especialidades Oftalmológicas (CEO) Achieves GHA's Certification for Excellence in Medical Travel Patient Experience
Clinic of Ophthalmology Specialties (Clínica de Especialidades Oftalmológicas - CEO), a recognized ophthalmological clinic in Medellín, Colombia,
More news about: Global Healthcare Accreditation
Feb 11, 2025, 20:17 ET Fundus Camera Market to Grow by USD 174.65 Thousand from 2025-2029, Driven by Rising Prevalence of Eye Diseases, Report on How AI is Redefining Market Landscape - Technavio
Non-mydriaticHybrid Fundus CamerasMydriatic Fundus CamerasROP Fundus CamerasEnd-userHospitalsOphthalmology ClinicsOthersGeographyNorth AmericaEurope
More news about: Technavio
Feb 11, 2025, 16:04 ET Independent Medical Alliance Expands International Fellowship Program with Nine New US-Based Senior Fellows
Fellow, Internal MedicineDr. Kristin Held (Texas) – Senior Fellow, Ophthalmology & Ophthalmic SurgeryDr. Mollie James (Missouri) – Senior Fellow,
More news about: Independent Medical Alliance
Feb 11, 2025, 13:05 ET 17 Innovators to be Inducted as the National Inventors Hall of Fame Class of 2025
tomography (OCT), a method for imaging subsurface structure of biological tissue in unprecedented detail. OCT has had a transformative impact in ophthalmology, improving the detection and management of sight-impairing eye diseases. OCT also is used in cardiology and across a growing range of applications
More news about: National Inventors Hall of Fame
Feb 11, 2025, 12:01 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Approved in Thailand
unmet need. The company's broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, neurology, endocrinology, ophthalmology and supportive care, although it is not confined to these areas. ST is a member of the World Orphan Drug Alliance (WODA). Additional information
More news about: Specialised Therapeutics
Feb 10, 2025, 08:00 ET Norlase Appoints Jacob Philipsen as Chairman of the Board of Directors
stewardship and decade of service, and look forward to his continued contributions as a member of the board as Norlase takes new and exciting strides in ophthalmology." "It is a great pleasure and privilege to serve on the Board of Norlase," said Dr. Philipsen. "The innovative capacity of the Norlase team
More news about: Norlase
Feb 10, 2025, 08:00 ET Norlase Appoints Jacob Philipsen as Chairman of the Board of Directors
stewardship and decade of service, and look forward to his continued contributions as a member of the board as Norlase takes new and exciting strides in ophthalmology." "It is a great pleasure and privilege to serve on the Board of Norlase," said Dr. Philipsen. "The innovative capacity of the Norlase team
More news about: Norlase
Feb 05, 2025, 10:11 ET Disposable Medical Supplies Market to Grow by USD 604.17 Billion from 2024-2028, Rising Demand for Disposable Medical Supplies Boosts Growth, AI-Powered Report - Technavio
sterilization consumables, and nonwoven medical supplies are key segments of the market. Wound care consumables, cardiovascular, cerebrovascular, ophthalmology, gynecology, urology, orthopedics, and hospitals are major end-users. Hygiene awareness and the need for PPE bundles have led to an increase in
More news about: Technavio
Feb 05, 2025, 09:34 ET Sectra keeps #1 position in customer satisfaction--earns 8 Best in KLAS awards within radiology and digital pathology
pathology modules are an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for cardiology, orthopaedics, ophthalmology and genomics in one single system. Adam Gale, CEO of KLAS, shared his thoughts on the 2025 winners:"Congratulations
More news about: Sectra
Feb 05, 2025, 09:00 ET EyeYon Medical Expands into China with New Subsidiary
expansion into China is driven by a profound understanding of the significant unmet needs within the country's ophthalmology sector. In particular, there will be a focus on corneal blindness, with more than 4 million patients in line for a cornea. By establishing a local
More news about: EyeYon Medical
Feb 05, 2025, 09:00 ET SECTRA KEEPS #1 POSITION IN CUSTOMER SATISFACTION--EARNS 8 BEST IN KLAS AWARDS WITHIN RADIOLOGY AND DIGITAL PATHOLOGY
pathology modules are an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for cardiology, orthopaedics, ophthalmology and genomics in one single system. Adam Gale, CEO of KLAS, shared his thoughts on the 2025 winners: "Congratulations
More news about: Sectra, Inc
Feb 05, 2025, 07:45 ET Affinia Therapeutics Appoints Hideo Makimura, M.D., Ph.D., as Chief Medical Officer
cardiovascular, metabolic, ophthalmology, neuroscience, oncology, and rare diseases while holding roles of increasing seniority at Johnson & Johnson (J&J) and Merck. He joins Affinia from J&J where he was most recently Global Vice President (VP) and Head of R&D for Ophthalmology, and before that,
More news about: Affinia Therapeutics
Feb 05, 2025, 05:00 ET From 0 to 100 Trillion: The Rise of Sanyou Bio's Intelligent Molecule Library
intelligence level of R&D. In terms of disease research, it focuses on 9 major human diseases, including tumors, autoimmune, infection, metabolism, ophthalmology, neurology, cardiovascular, anti-aging, and various rare diseases. In terms of target exploration, it concentrates on in-depth research over
More news about: Sanyou Bio
Feb 05, 2025, 03:59 ET Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan
lives and psychological wellbeing.4,5 Marci English, Vice President, Head of BioPharma and Ophthalmology Development, Astellas"Today's submission comes as good news to people in Japan living with geographic
More news about: Astellas Pharma Inc.
Feb 04, 2025, 08:00 ET Yale Medicine Takes Top Spots in National and State Rankings
for care in cancer, dermatology, neurosurgery, ophthalmology, pediatrics, surgery, and urology. Aligned
More news about: Yale School of Medicine
Feb 04, 2025, 07:00 ET InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com. Forward-Looking
More news about: InMode LTD.
Feb 04, 2025, 01:30 ET Astellas Makes Announcement about Management Structure
company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
Feb 03, 2025, 17:41 ET Glaucoma Research Foundation to Host 14th Annual Glaucoma 360 Event in San Francisco
glaucoma patients. Pioneering glaucoma researcher and clinician Carla Siegfried, MD, Distinguished Professor of Ophthalmology and Vice Chair for Diversity, Equity and Professionalism at Washington University, St. Louis,
More news about: Glaucoma Research Foundation
Feb 03, 2025, 10:58 ET HealthEdge Investment Partners Announces Recapitalization of Western Microsurgical
centers ("ASCs"), and specialty clinics. WMS specializes in surgical microscopy, equipment, and supplies, used in specialty spine, neuro, ENT, and ophthalmology procedures. The company provides an array of support services including maintenance, break-fix repair, sales, and rentals to its customers. The
More news about: HealthEdge Investment Partners, LLC
Feb 03, 2025, 10:00 ET SightMD New Jersey Introduces Bladeless LASIK Eye Surgery at Toms River Surgical Center
provider for the ophthalmology sector including SightMD in New York, SightMD Connecticut, SightMD New Jersey, SightMD Massachusetts and SightMD Pennsylvania. It has over 140 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory
More news about: SightMD New Jersey
Feb 03, 2025, 08:30 ET InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode LTD
Jan 30, 2025, 01:30 ET Ambulatory Surgical Centers Market to Grow by USD 25.4 Billion (2024-2028), Rise in Cataract Ambulatory Surgeries Boosts Market, Report on AI-powered Market Evolution - Technavio
healthcare industry. These facilities specialize in diagnostic procedures and minor operations, including gastroenterology, plastic surgery, dentistry, ophthalmology, and orthopedics. With advancements in medical technology, more chronic disorders and nonsurgical procedures are being performed in these centers.
More news about: Technavio
Jan 29, 2025, 05:37 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY25
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Ltd